| A comprehensive review on microbial l‐asparaginase: Bioprocessing, characterization, and industrial applications S Chand, RV Mahajan, JP Prasad, DK Sahoo, KN Mihooliya, MS Dhar, ... Biotechnology and applied biochemistry 67 (4), 619-647, 2020 | 91 | 2020 |
| International standards for monoclonal antibodies to support pre-and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities … S Prior, SE Hufton, B Fox, T Dougall, P Rigsby, A Bristow, ... MAbs 10 (1), 129-142, 2018 | 22 | 2018 |
| Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India K Chatterjee, S Zaman, R Chaurasia, S Singh, SD Keil, S Tewari, A Bisht, ... Asian journal of transfusion science 10 (2), 127-131, 2016 | 11 | 2016 |
| Bioactive molecules from fungal endophytes and their applications in pharmaceutical industries: challenges and future scope K Anand, V Kumar, IB Prasher, M Sethi, H Raj, H Ranjan, S Chand, ... Journal of Basic Microbiology 63 (7), 690-708, 2023 | 5 | 2023 |
| Cancer informatics analysis indicates high CHAC2 associated with unfavorable prognosis in breast cancer S Chand, V Mehta, RK Sharma, AR Anvikar, H Chander Frontiers in Oncology 12, 1058931, 2022 | 5 | 2022 |
| L-asparaginase from Bacillus flexus strain SS: Isolation, Screening, Production Process Optimization, Purification, and Anticancer Activity S Chand, KN Mihooliya, DK Sahoo, JP Prasad, G Sharma Applied Biochemistry and Microbiology 58 (4), 416-427, 2022 | 4 | 2022 |
| Comparative analytical profiling of bevacizumab biosimilars marketed in India: a national control laboratory study A Prakash, NN Mishra, U Vaish, S Sharma, A Anand, RV Mahajan, ... 3 Biotech 10, 1-13, 2020 | 3 | 2020 |
| Role of selective Bioactive Compounds as an Angiotensin Converting Enzyme Inhibitor H Khan, T Husain, M Kataria, A Seth, MZ Malik, A Dash, S Chand, ... bioRxiv, 2020.08. 17.254359, 2020 | 3 | 2020 |
| Quality assurance of rituximab (anti-CD 20) antibodies by potency testing: determining the system suitability criteria and sample acceptance criteria S Chand, B Kumar, VM Prathap, S Singh, RV Mahajan Current Science, 2513-2518, 2018 | 3 | 2018 |
| Determination of minimum inhibitory concentration (MIC) of routinely used disinfectants against microflora Isolated from clean rooms S Chand, K Saha, PK Singh, S Sri, N Malik Int J Curr Microbiol Appl Sci 5 (1), 334-341, 2016 | 3 | 2016 |
| A reliable assay for ensuring the biological activity of anti T lymphocyte immunoglobulin as an alternate to compendial flow cytometry method S Chand, U Vaish, A Sharma, NN Mishra, JP Prasad, RV Mahajan Biologicals 65, 33-38, 2020 | 1 | 2020 |
| Advances in Production of Therapeutic Monoclonal Antibodies RV Mahajan, S Chand, MP Singh, A Kestwal, S Singh High Value Fermentation Products: Human Health 1, 165-191, 2019 | 1 | 2019 |
| Assessment of structural behaviour of a new L-asparaginase and SAXS data-based evidence for catalytic activity in its monomeric form KN Mihooliya, J Nandal, N Kalidas, S Chand, DK Verma, ... International Journal of Biological Macromolecules 253, 126803, 2023 | | 2023 |
| Cost effective and reliable cell based ELISA as an alternative method of flow cytometry for assessment of binding activity of Vedolizumab S Shalini, A Sharma, NN Mishra, RK Sharma, H Chander, AR Anvikar, ... Heliyon 9 (2), 2023 | | 2023 |
| National Control Laboratory Assessment of Quality of Rituximab Biosimilars in India NN Mishra, A Sharma, S Shalini, S Sharma, P Jain, RK Sharma, ... Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 41 (5), 260-274, 2022 | | 2022 |
| Synergistic Combinatorial effect of L-asparaginase and Trastuzumab against HER2+ breast cancer cells S Chand, A Sharma, JP Prasad, G Sharma Research Journal of Pharmacy and Technology 15 (12), 5819-5824, 2022 | | 2022 |
| Estimation of potency of Hepatitis B immunoglobulin marketed in India to evaluate the manufacturer's production consistency: Role of National Control Laboratory J Meena, S Sood, N Rani, R Bisht, M Kiran, R Chhabra, S Singh, S Chand Biologicals: journal of the International Association of Biological …, 2019 | | 2019 |
| Comparative evaluation for safety & potency of inactivated Cell Culture Rabies Vaccines from four Indian manufacturers S Chand | | |
Dr. Girish SharmaProfessor of Biotechnology, Amity University, NoidaVerified email at amity.edu
